Savara Inc reports results for the quarter ended in March - Earnings Summary

Savara

13/05/2024 14:32

* Savara Inc  SVRA.OQ  reported a quarterly adjusted loss
of 11
cents​​ per share for the quarter ended in March, lower than the
same quarter last year, when the company reported EPS of -7
cents.  The mean expectation of six analysts for the quarter was
for a loss of 10 cents per share. Wall Street expected
results to range from -11 cents to -9 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Savara Inc's reported EPS for the quarter was a loss of 11
cents​.
    * The company reported a quarterly loss of $20.35 million.
    * Savara Inc shares had fallen by 6.5% this quarter and
lost 1.0%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Savara Inc is
$8.00 
This summary was machine generated from LSEG data May 13 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024                     -0.11          
 Dec. 31 2023      -0.10          -0.09          Beat
 Sep. 30 2023      -0.07          -0.10          Missed
 Jun. 30 2023      -0.08          -0.07          Beat